Oncotelic and Sapu Nano Announce DeciparticleTM Led Biomarker Framework Identifying Tumors Most Likely to Respond to IV Sapu003, an Intravenous Everolimus Nanomedicine
AGOURA HILLS, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc.…
Reebok Launches Nano X5 Edge Training Shoes
The Official Shoe of Fitness Just Leveled UpBOSTON, Mass. – Nov. 21st,…
Authentix Inc. Signs Cooperation and License Agreement with LEONHARD KURZ Stiftung & Co. KG. to Deliver High-Volume Production of QUANTUM stripe
ADDISON, Texas, Oct. 29, 2025 /PRNewswire/ -- Authentix, a pioneer in Nano…
